Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Shares Outstanding (2021 - 2026)

HeartSciences' Shares Outstanding history spans 6 years, with the latest figure at $536767.0 for Q1 2026.

  • For Q1 2026, Shares Outstanding rose 41.09% year-over-year to $536767.0; the TTM value through Jan 2026 reached $536767.0, up 41.09%, while the annual FY2025 figure was $1.1 million, 65.4% up from the prior year.
  • Shares Outstanding reached $3.2 million in Q1 2026 per HSCS's latest filing, up from $579839.0 in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $8.2 million in Q4 2022 to a low of $10000.0 in Q1 2022.
  • Average Shares Outstanding over 5 years is $1.7 million, with a median of $579839.0 recorded in 2025.
  • Peak YoY movement for Shares Outstanding: soared 83398.59% in 2023, then plummeted 95.44% in 2024.
  • A 5-year view of Shares Outstanding shows it stood at $8.2 million in 2022, then plummeted by 95.37% to $380440.0 in 2023, then changed by 0.0% to $380440.0 in 2024, then changed by 0.0% to $380440.0 in 2025, then skyrocketed by 41.09% to $536767.0 in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Shares Outstanding are $536767.0 (Q1 2026), $380440.0 (Q4 2025), and $429901.0 (Q3 2025).